We are live on ! Find out more
LLY icon

Eli Lilly

1,118 hedge funds and large institutions have $61B invested in Eli Lilly in 2015 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 379 increasing their positions, 463 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $458M | Put options by funds: $261M

23% more funds holding in top 10

Funds holding in top 10: 3543 (+8)

5% more capital invested

Capital invested by funds: $58B → $61B (+$3.09B)

1% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 75

0.13% more ownership

Funds ownership: 75.64%75.78% (+0.13%)

1% less funds holding

Funds holding: 1,1301,118 (-12)

18% less repeat investments, than reductions

Existing positions increased: 379 | Existing positions reduced: 463

Holders
1,118
Holders Change
-12
Holders Change %
-1.06%
% of All Funds
29.78%
Holding in Top 10
43
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+22.86%
% of All Funds
1.15%
New
76
Increased
379
Reduced
463
Closed
75
Calls
$458M
Puts
$261M
Net Calls
+$197M
Net Calls Change
+$332M
Name Holding Trade Value Shares
Change
Change in
Stake
AI
901
Accredited Investors
Minnesota
$312K +$926 +13 +0.3%
GLI
902
Guardian Life Insurance
New York
$311K -$93.8K -1,317 -24%
EBSAM
903
Eubel Brady & Suttman Asset Management
Ohio
$310K
CPC
904
Cookson Peirce & Co
Pennsylvania
$307K
CWM
905
Confluence Wealth Management
Oregon
$306K +$3.77K +53 +1%
IAM
906
Impax Asset Management
New Hampshire
$305K +$1.28K +18 +0.4%
NA
907
NSB Advisors
New York
$303K
AEPG
908
American Economic Planning Group
New Jersey
$301K +$214 +3 +0.1%
P
909
Pitcairn
Pennsylvania
$300K -$5.91K -83 -2%
AA
910
AlphaMark Advisors
Kentucky
$298K
HDIM
911
Hanson & Doremus Investment Management
Vermont
$297K
KP
912
Keel Point
Alabama
$296K +$290K +4,071 New
FNFDCM
913
Folger Nolan Fleming Douglas Capital Management
District of Columbia
$295K
LK
914
Lumbard & Kellner
New Hampshire
$291K
NIM
915
Nexus Investment Management
Ontario, Canada
$291K
PWLP
916
Prio Wealth Limited Partnership
Massachusetts
$291K
WT
917
Washington Trust
Rhode Island
$291K
TCB
918
Texas Capital Bancshares
Texas
$290K -$23K -323 -7%
EWM
919
Endurance Wealth Management
Rhode Island
$290K
SEC
920
Seven Eight Capital
New York
$290K +$284K +3,991 New
BRA
921
Bender Robert & Associates
California
$288K +$28.1K +395 +8%
MA
922
MCF Advisors
Kentucky
$286K +$1.28K +18 +0.5%
ATC
923
Argent Trust Co
Tennessee
$284K +$27.7K +389 +11%
MSR
924
Main Street Research
Connecticut
$281K
SC
925
Savant Capital
Illinois
$275K +$2.85K +40 +1%

LLY Hedge Fund Activity: Q1 2015 in Review

1,118 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2015, worth a combined $61B — up 5.3% from $58B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new LLY positions and 75 closed out — a net gain of 1 holder — while 379 added to existing stakes and 463 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $352M. The largest seller was T. Rowe Price Associates, cutting an estimated $254M.

  • 1,118 institutional investors held Eli Lilly (LLY) as of Q1 2015, down from 1,130 in Q4 2014.
  • Funds reported $61B of Eli Lilly stock for Q1 2015, up 5.3% quarter-over-quarter.
  • 76 funds opened new Eli Lilly positions in Q1 2015 and 75 closed out, a net change of +1 holder.
  • The largest Eli Lilly buyer in Q1 2015 was Janus Henderson Investors US, an estimated $352M added.
  • The largest Eli Lilly seller in Q1 2015 was T. Rowe Price Associates, an estimated $254M sold.

Based on aggregated 13F filings for Q1 2015.